SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 277,308.14 |
Enterprise Value ($M) | 303,858.14 |
Book Value ($M) | 40,424.00 |
Book Value / Share | 15.95 |
Price / Book | 6.86 |
NCAV ($M) | -30,777.00 |
NCAV / Share | -12.14 |
Price / NCAV | -9.01 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.18 |
Return on Assets (ROA) | 0.13 |
Return on Equity (ROE) | 0.35 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.22 |
Current Ratio | 1.47 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 38,205.00 |
Assets | 112,630.00 |
Liabilities | 68,982.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.66 | 7.73 | |
13G/A | BlackRock Inc. | 8.00 | -6.13 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
558,972 | 6,593,727 | 8.48 | |
591,950 | 4,300,129 | 13.77 | |
1,143,411 | 6,584,460 | 17.37 | |
774,733 | 6,491,726 | 11.93 | |
(click for more detail) |
Similar Companies | |
---|---|
HYAC – Haymaker Acquisition Corp. 4 | JNJ – Johnson & Johnson |
LLY – Eli Lilly and Company | NUVB – Nuvation Bio Inc. |
OGN – Organon & Co. |